NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
16.69
+0.10 (0.60%)
Oct 26, 2026, 4:00 PM EDT - Market closed
NeoGenomics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,144 | 1,522 | 2,115 | 2,062 | 1,167 | 4,201 | |
Market Cap Growth | 60.53% | -28.07% | 2.57% | 76.72% | -72.22% | -29.73% |
Enterprise Value | 2,447 | 1,768 | 2,334 | 2,266 | 1,335 | 4,271 |
Last Close Price | 16.69 | 11.76 | 16.48 | 16.18 | 9.24 | 34.12 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | 61.84 | 83.58 | 103.91 | 266.98 | 266.98 | 266.98 |
PS Ratio | 2.80 | 2.09 | 3.20 | 3.49 | 2.29 | 8.67 |
PB Ratio | 2.72 | 1.82 | 2.34 | 2.19 | 1.17 | 3.79 |
P/TBV Ratio | - | 59.23 | 53.03 | 45.19 | 17.42 | 30.26 |
P/OCF Ratio | 97.25 | 290.94 | 301.21 | - | - | - |
PEG Ratio | 1.17 | 1.70 | 6.21 | 6.21 | 6.21 | 6.21 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.19 | 2.43 | 3.53 | 3.83 | 2.62 | 8.82 |
EV/EBITDA Ratio | 100.60 | - | 1607.33 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.57 | 0.49 | 0.67 | 0.65 | 0.61 | 0.55 |
Debt / EBITDA Ratio | 13.68 | 52.97 | 45.92 | - | - | - |
Net Debt / Equity Ratio | 0.39 | 0.30 | 0.24 | 0.21 | 0.17 | 0.09 |
Net Debt / EBITDA Ratio | 12.45 | -137.20 | 150.48 | -8.16 | -2.07 | -1.49 |
Net Debt / FCF Ratio | -41.17 | -11.47 | -6.42 | -6.40 | -1.78 | -1.07 |
Asset Turnover | 0.56 | 0.49 | 0.40 | 0.35 | 0.28 | 0.34 |
Inventory Turnover | 14.02 | 14.95 | 14.56 | 14.33 | 13.50 | 11.23 |
Quick Ratio | 3.04 | 3.61 | 1.78 | 5.67 | 6.22 | 7.21 |
Current Ratio | 3.60 | 4.26 | 1.98 | 6.20 | 6.73 | 7.81 |
Return on Equity (ROE) | -6.33% | -12.42% | -8.54% | -9.07% | -13.70% | -0.93% |
Return on Assets (ROA) | -1.89% | -2.90% | -2.68% | -3.53% | -5.30% | -5.19% |
Return on Invested Capital (ROIC) | -3.80% | -6.31% | -6.30% | -8.37% | -12.88% | -13.03% |
Return on Capital Employed (ROCE) | -3.30% | -5.50% | -5.30% | -6.10% | -9.30% | -6.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -2.41% | -7.10% | -3.72% | -4.26% | -12.36% | -0.20% |
FCF Yield | -0.34% | -1.43% | -1.61% | -1.49% | -8.30% | -2.16% |
Buyback Yield / Dilution | -1.26% | -1.14% | -0.92% | -1.03% | -3.55% | -7.31% |